Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells
Débora Dummer Meira(Instituto Nacional de Câncer - INCA), Carlos Gil Ferreira(Instituto Nacional do Câncer)
Cited by 50